Search Results
Mar 27, 2026, 09:00 ET DEEPX Secures 27 Commercial Orders Across 8 Countries Within 7 Months of Mass Production
inference.New Products: DX-M1M and DX-AIPlayerAlongside its commercial order momentum, DEEPX has launched two mass-production product lines designed to reduce integration friction for industrial developers across its key markets:DX-M1M (M.2 Module): A standard
More news about: DEEPX
Mar 26, 2026, 11:00 ET Mesirow Alternative Credit and GMO Payment Gateway Announce Strategic Partnership
GatewayGMO Payment Gateway, Inc. provides payment-related services that support the customer's online and cashless migration and digital transformation (DX). Annual transaction value exceeds 22 trillion yen and our online comprehensive payment services have been adopted by over 150,000 merchants such as EC
More news about: Mesirow Financial Holdings, Inc.
Mar 25, 2026, 12:24 ET Samsung presenta los nuevos Galaxy A57 5G y Galaxy A37 5G, con capacidades mejoradas a un precio increíble
últimas innovaciones al alcance de más usuarios de Galaxy", declaró TM Roh, Director Ejecutivo, presidente y director de la división Device eXperience (DX) de Samsung Electronics. "Gracias a las capacidades fundamentales de Samsung, combinadas con la avanzada tecnología Awesome Intelligence, los Galaxy
More news about: Samsung Mexico
Mar 25, 2026, 10:45 ET Veterinary Diagnostics Market Size Worth USD 19.63 Billion by 2032, Exclusive Report by Maximize Market Research
AI-Enabled BreakthroughsIn February 2026, IDEXX Laboratories Inc.: Expanded its diagnostic ecosystem with IDEXX Cancer Dx canine lymphoma and inVue Dx platforms, enhancing early disease detection and workflow efficiency. In January 2025, Zoetis Services LLC: Launched AI-powered
More news about: Maximize Market Research Pvt. Ltd.
Mar 25, 2026, 08:00 ET Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced
More news about: Co-Diagnostics
Mar 24, 2026, 10:03 ET Regal is Bringing Five Decades of LOLz to Theatres in April with the "Legends of Laughs" Series
Regal is focused on delivering the best moviegoing experience by providing our guests with the largest selection of premium large formats (including 4DX, IMAX, RPX, and ScreenX), the only unlimited subscription program, and enhanced food and beverage offerings to make every visit to the theatre a truly
More news about: Regal
Mar 24, 2026, 08:57 ET RNR Tire Express Launches DX3 Brands as New Multi-Brand Franchisor
"DX3 Brands marks the next phase in our evolution," said Adam Sutton, CEO of RNR Tire Express and DX3 Brands. "Over the past 25 years, we've built a powerful franchise system with RNR Tire Express. Now with DX3 Brands, we're leveraging that infrastructure,
More news about: RNR Tire Express
Mar 23, 2026, 11:58 ET "Project Hail Mary" Drives Strong Weekend for Regal Cineworld as Premium Formats and Top Locations Lead Performance
It's ambitious, original, visually striking, and clearly capturing the imagination of audiences, especially in premium formats like IMAX, RPX, and 4DX," said Eduardo Acuña, Chief Executive Officer of Regal Cineworld.Premium formats were a significant driver of performance with 50% of Regal's total
More news about: Regal
Mar 23, 2026, 08:50 ET Abbott completes acquisition of Exact Sciences
and supporting personalized treatments. This includes the Cologuard® test, a market-leading noninvasive colorectal cancer screening option; Oncotype DX®, which informs personalized treatment decisions for patients with early-stage breast cancer; Oncodetect®, a tumor-informed molecular residual disease
More news about: Abbott
Mar 23, 2026, 04:45 ET Fujitsu-developed traffic simulation system utilized in Maebashi City's public transportation planning
comprehensive traffic simulation system, developed under contract for Ministry of Land, Infrastructure, Transport and Tourism (MLIT)-led regional transportation DX promotion project COMmmmONS, has been adopted for Maebashi City Regional Public Transportation Plan, published by local government on March 23, 2026.
More news about: Fujitsu Limited
Mar 20, 2026, 09:00 ET Abbott acquisition of Exact Sciences set to close on March 23, 2026
pipelineExact Sciences' product offerings include the Cologuard® test, a market-leading noninvasive colorectal cancer screening option; Oncotype DX®, which informs personalized treatment decisions for patients with early-stage breast cancer; Oncodetect®, a tumor informed molecular residual disease
More news about: Abbott
Mar 20, 2026, 08:00 ET Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Company has signed an agreement for CoSara Diagnostics Pvt. Ltd. ("CoSara"), the Indian joint venture between Co-Dx and Ambalal
More news about: Co-Diagnostics
Mar 19, 2026, 09:30 ET CJ 4DPLEX and AMC Theatres Launch First Four Premium SCREENX and 4DX Locations in the United States
only SCREENX can deliver.About 4DX4DX provides the best synesthetic viewing experience that connects the audience with movies through its state-of-the-art motion-seats and 21 environmental effects that include water, wind and scents. The 4DX theater is a special theater where you can
More news about: CJ 4DPLEX
Mar 19, 2026, 09:30 ET CJ 4DPLEX and AMC Theatres Launch First Four Premium SCREENX and 4DX Locations in the United States
only SCREENX can deliver.About 4DX4DX provides the best synesthetic viewing experience that connects the audience with movies through its state-of-the-art motion-seats and 21 environmental effects that include water, wind and scents. The 4DX theater is a special theater where you can
More news about: CJ 4DPLEX
Mar 18, 2026, 09:15 ET Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
PGDx elio® plasma focus™ Dx alongside Illumina's FDA-approved
More news about: Illumina, Inc.
Mar 18, 2026, 01:23 ET Golden Helix geht eine Partnerschaft mit den Austrian Human Genetics Labs ein, um Fortschritte in der Genommedizin voranzutreiben
der Schlüsselinfrastruktur des Humangenomprojekts hier in Österreich nutzen. In dieser Hinsicht ist die Möglichkeit, die Software als Medizinprodukt im DX-Modus zu betreiben, entscheidend für unsere Routinetests. Gleichzeitig nutzen wir skalierbare und leistungsstarke Software, um Forschungsprojekte zum
More news about: Golden Helix, Inc.
Mar 18, 2026, 01:05 ET transcosmos signs a partnership agreement with the Tokyo University of Pharmacy and Life Sciences to promote pharmacist operational transformation to address the 2040 Problem
pharmaceutical education programs by leveraging expertise in digital transformation (DX) and business process outsourcing (BPO).Through education and research that combine professional pharmaceutical knowledge with DX/BPO expertise, contribute to developing next-generation talent who can support
More news about: transcosmos inc.
Mar 17, 2026, 09:00 ET Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced
More news about: Co-Diagnostics
Mar 17, 2026, 08:00 ET Golden Helix Partners with the Austrian Human Genetics Labs to Drive Advancements in Genomic Medicine
as part of the key infrastructure of the Human Genome Project here in Austria. In that regard, the ability to run the software as a medical device in DX mode is key to our routine testing efforts. At the same time, we leverage scalable and high-performing software to run research projects on human genomes
More news about: Golden Helix, Inc.
Mar 17, 2026, 08:00 ET Golden Helix Partners with the Austrian Human Genetics Labs to Drive Advancements in Genomic Medicine
as part of the key infrastructure of the Human Genome Project here in Austria. In that regard, the ability to run the software as a medical device in DX mode is key to our routine testing efforts. At the same time, we leverage scalable and high-performing software to run research projects on human genomes
More news about: Golden Helix, Inc.
Mar 16, 2026, 09:00 ET Co-Diagnostics to Present at Medical Korea 2026
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that Co-Dx will accompany
More news about: Co-Diagnostics
Mar 13, 2026, 01:29 ET OMRON skizziert datengestützten Kurs bis 2030 für das Europageschäft
unseren Kunden zu vertiefen und erneut starkes Wachstum zu erzielen, um uns zu einem GEMBA-DX-Unternehmen zu transformieren," sagte Junta Tsujinaga, Präsident und Geschäftsführer der OMRON Corporation. „GEMBA DX führt hochwertige Daten aus Geräten, eine der Stärken von OMRON, mit weiteren Daten aus
More news about: OMRON Corporation
Mar 13, 2026, 01:28 ET OMRON Charts Data-Driven Path to 2030 for European Business
trust with our customers and once again achieve strong growth in order to transform ourselves into GEMBA DX company," said Junta Tsujinaga, President & CEO, OMRON Corporation. "GEMBA DX fuses and multiplies high-quality data obtained from devices, which is one of OMRON's strengths, with other
More news about: OMRON Corporation
Mar 13, 2026, 00:39 ET Workflow Services Supports Walgreens National Colorectal Cancer Initiative to Close Screening Gaps; Leverages Cologuard® Tests to Expand Reach
during, and after a cancer diagnosis. The company's growing portfolio includes well-established brands such as Cologuard® and Oncotype DX®, along with innovative solutions like the Cancerguard® test for multi-cancer early detection and the Oncodetect® test for
More news about: Workflow Services
Mar 12, 2026, 09:00 ET Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies
automated, self-contained biological analysis performed by Co-Dx's PCR platform, and encompasses both the Co-Dx instrument and its proprietary test cups designed for use with the system.*The Co-Dx PCR platform (including the PCR Home®, PCR Pro®, mobile app, and all associated tests) is subject to
More news about: Co-Diagnostics